Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani

Vaccine
R Gamboa-LeónC B Palatnik-de-Sousa

Abstract

The nucleoside hydrolase (NH36) of Leishmania (L.) donovani is a vital enzyme which releases purines or pyrimidines of foreign DNA to be used in the synthesis of parasite DNA. As a bivalent DNA vaccine, the VR1012-NH36 was immunoprotective against visceral and cutaneous murine leishmaniasis. In this work we tested the immunotherapy against Leishmania (L.) chagasi infection, using two doses of 100 or 20 microg VR1012-NH36 vaccine (i.m. route), and, as a possible immunomodulator, aqueous garlic extract (8 mg/kg/day by the i.p. route), which was effective in immunotherapy of cutaneous murine leishmaniasis. Liver parasitic load was significantly reduced following treatment with 100 microg (91%) and 20 microg (77%) of the DNA vaccine, and by 20 microg DNA vaccine and garlic extract (76%) (p=0.023). Survival was 33% for saline controls, 100% for the 100 microg vaccine, and 83 and 67% for the 20 microg vaccine with and without garlic extract addition, respectively. Garlic treatment alone did not reduce parasite load (p>0.05), but increased survival (100%). The NH36-DNA vaccine was highly effective as a new tool for the therapy and control of visceral leishmaniasis, while the mild protective effect of garlic might be related to an unsp...Continue Reading

Citations

Dec 17, 2014·Clinical & Translational Immunology·Rajiv Kumar, Christian Engwerda
Aug 27, 2014·Future Microbiology·Forough Khadem, Jude E Uzonna
Aug 22, 2007·Journal of Biomedicine & Biotechnology·Eric Dumonteil
Feb 28, 2007·Journal of Ethnobiology and Ethnomedicine·Cheryl LansWilli Boepple
Jan 30, 2010·Expert Review of Vaccines·Joana A CarvalhoGabriel A Monteiro
Jul 31, 2008·Expert Review of Vaccines·Clarisa B Palatnik-de-SousaGulnara P Borja-Cabrera
Jul 2, 2008·Expert Opinion on Drug Delivery·Sudipta Bhowmick, Nahid Ali
Feb 4, 2016·Human Vaccines & Immunotherapeutics·Elissa M HudspethMaria Elena Bottazzi
Oct 24, 2007·Scandinavian Journal of Immunology·M R Gamboa-LeónE Dumonteil
Apr 11, 2015·Journal of Immunological Methods·Keerti Jain, N K Jain
May 14, 2016·Parasites & Vectors·Saumya SrivastavaSarman Singh
May 28, 2011·International Immunopharmacology·Rajeev Nagill, Sukhbir Kaur
Dec 25, 2015·PLoS Neglected Tropical Diseases·Elisangela Oliveira FreitasClarisa B Palatnik-de-Sousa
Feb 2, 2013·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C Teixeira, R Gomes
Sep 27, 2018·International Journal of Veterinary Science and Medicine·Khaled Abo-El-Sooud
Mar 17, 2020·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·P G Vathsala, P Krishna Murthy
Mar 23, 2017·Frontiers in Immunology·Micheli Luize Barbosa SantosClarisa Beatriz Palatnik-de-Sousa
Oct 23, 2019·Vaccines·Shubhranshu ZutshiBhaskar Saha
Jan 24, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Asal KatebiSoheila Ajdary
Apr 8, 2021·Parasitology Research·Santanu Sasidharan, Prakash Saudagar
Jul 8, 2021·Biologicals : Journal of the International Association of Biological Standardization·Vikas Kushwaha, Sukhbir Kaur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.